Selected research
Market Structure
Global Female Emergency Contraceptive Pill Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Female Emergency Contraceptive Pill market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Female Emergency Contraceptive Pill is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Female Emergency Contraceptive Pill is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Female Emergency Contraceptive Pill is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Female Emergency Contraceptive Pill is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Female Emergency Contraceptive Pill include Foundation Consumer Healthcare, Gedeon Richter, HLL Life Care, HRA Pharma, Lupin, Mankind Pharma, Piramal, Syzygy Healthcare and Regenex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Female Emergency Contraceptive Pill market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Female Emergency Contraceptive Pill and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Female Emergency Contraceptive Pill sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Female Emergency Contraceptive Pill market size, projected growth trends, production technologies, key applications, and end-use industries.
Female Emergency Contraceptive Pill Segment by Company
Foundation Consumer Healthcare
Gedeon Richter
HLL Life Care
HRA Pharma
Lupin
Mankind Pharma
Piramal
Syzygy Healthcare
Regenex
Zizhu Pharma
Sine Pharma
Zhejiang Xianju Pharma
Female Emergency Contraceptive Pill Segment by Type
Levonorgestrel
Ulipristal Acetate
Female Emergency Contraceptive Pill Segment by Application
Online
Offline
Female Emergency Contraceptive Pill Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Female Emergency Contraceptive Pill market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Female Emergency Contraceptive Pill and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Female Emergency Contraceptive Pill.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Female Emergency Contraceptive Pill market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Female Emergency Contraceptive Pill manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Female Emergency Contraceptive Pill in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Female Emergency Contraceptive Pill in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Levonorgestrel
- Ulipristal Acetate
Applications
- Online
- Offline
Companies covered
- Foundation Consumer Healthcare
- Gedeon Richter
- HLL Life Care
- HRA Pharma
- Lupin
- Mankind Pharma
- Piramal
- Syzygy Healthcare
- Regenex
- Zizhu Pharma
- Sine Pharma
- Zhejiang Xianju Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Female Emergency Contraceptive Pill Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Female Emergency Contraceptive Pill Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Female Emergency Contraceptive Pill Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Female Emergency Contraceptive Pill Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Female Emergency Contraceptive Pill Market Dynamics
- 2.1 Female Emergency Contraceptive Pill Industry Trends
- 2.2 Female Emergency Contraceptive Pill Industry Drivers
- 2.3 Female Emergency Contraceptive Pill Industry Opportunities and Challenges
- 2.4 Female Emergency Contraceptive Pill Industry Restraints
3 Female Emergency Contraceptive Pill Market by Manufacturers
- 3.1 Global Female Emergency Contraceptive Pill Revenue by Manufacturers (2021-2026)
- 3.2 Global Female Emergency Contraceptive Pill Sales by Manufacturers (2021-2026)
- 3.3 Global Female Emergency Contraceptive Pill Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Female Emergency Contraceptive Pill Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Female Emergency Contraceptive Pill Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Female Emergency Contraceptive Pill Manufacturers, Product Type & Application
- 3.7 Global Female Emergency Contraceptive Pill Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Female Emergency Contraceptive Pill Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Female Emergency Contraceptive Pill Players Market Share by Revenue in 2025
- 3.8.3 2025 Female Emergency Contraceptive Pill Tier 1, Tier 2, and Tier 3
4 Female Emergency Contraceptive Pill Market by Type
- 4.1 Female Emergency Contraceptive Pill Type Introduction
- 4.1.1 Levonorgestrel
- 4.1.2 Ulipristal Acetate
- 4.2 Global Female Emergency Contraceptive Pill Sales by Type
- 4.2.1 Global Female Emergency Contraceptive Pill Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Female Emergency Contraceptive Pill Sales by Type (2021-2032)
- 4.2.3 Global Female Emergency Contraceptive Pill Sales Market Share by Type (2021-2032)
- 4.3 Global Female Emergency Contraceptive Pill Revenue by Type
- 4.3.1 Global Female Emergency Contraceptive Pill Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Female Emergency Contraceptive Pill Revenue by Type (2021-2032)
- 4.3.3 Global Female Emergency Contraceptive Pill Revenue Market Share by Type (2021-2032)
5 Female Emergency Contraceptive Pill Market by Application
- 5.1 Female Emergency Contraceptive Pill Application Introduction
- 5.1.1 Online
- 5.1.2 Offline
- 5.2 Global Female Emergency Contraceptive Pill Sales by Application
- 5.2.1 Global Female Emergency Contraceptive Pill Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Female Emergency Contraceptive Pill Sales by Application (2021-2032)
- 5.2.3 Global Female Emergency Contraceptive Pill Sales Market Share by Application (2021-2032)
- 5.3 Global Female Emergency Contraceptive Pill Revenue by Application
- 5.3.1 Global Female Emergency Contraceptive Pill Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Female Emergency Contraceptive Pill Revenue by Application (2021-2032)
- 5.3.3 Global Female Emergency Contraceptive Pill Revenue Market Share by Application (2021-2032)
6 Global Female Emergency Contraceptive Pill Sales by Region
- 6.1 Global Female Emergency Contraceptive Pill Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Female Emergency Contraceptive Pill Sales by Region (2021-2032)
- 6.2.1 Global Female Emergency Contraceptive Pill Sales by Region (2021-2026)
- 6.2.2 Global Female Emergency Contraceptive Pill Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Female Emergency Contraceptive Pill Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Female Emergency Contraceptive Pill Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Female Emergency Contraceptive Pill Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Female Emergency Contraceptive Pill Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Female Emergency Contraceptive Pill Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Female Emergency Contraceptive Pill Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Female Emergency Contraceptive Pill Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Female Emergency Contraceptive Pill Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Female Emergency Contraceptive Pill Revenue by Region
- 7.1 Global Female Emergency Contraceptive Pill Revenue by Region
- 7.1.1 Global Female Emergency Contraceptive Pill Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Female Emergency Contraceptive Pill Revenue by Region (2021-2026)
- 7.1.3 Global Female Emergency Contraceptive Pill Revenue by Region (2027-2032)
- 7.1.4 Global Female Emergency Contraceptive Pill Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Female Emergency Contraceptive Pill Revenue (2021-2032)
- 7.2.2 North America Female Emergency Contraceptive Pill Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Female Emergency Contraceptive Pill Revenue (2021-2032)
- 7.3.2 Europe Female Emergency Contraceptive Pill Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Female Emergency Contraceptive Pill Revenue (2021-2032)
- 7.4.2 Asia-Pacific Female Emergency Contraceptive Pill Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Female Emergency Contraceptive Pill Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Female Emergency Contraceptive Pill Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Foundation Consumer Healthcare
- 8.1.1 Foundation Consumer Healthcare Company Information
- 8.1.2 Foundation Consumer Healthcare Business Overview
- 8.1.3 Foundation Consumer Healthcare Female Emergency Contraceptive Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Foundation Consumer Healthcare Female Emergency Contraceptive Pill Product Portfolio
- 8.1.5 Foundation Consumer Healthcare Recent Developments
- 8.2 Gedeon Richter
- 8.2.1 Gedeon Richter Company Information
- 8.2.2 Gedeon Richter Business Overview
- 8.2.3 Gedeon Richter Female Emergency Contraceptive Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Gedeon Richter Female Emergency Contraceptive Pill Product Portfolio
- 8.2.5 Gedeon Richter Recent Developments
- 8.3 HLL Life Care
- 8.3.1 HLL Life Care Company Information
- 8.3.2 HLL Life Care Business Overview
- 8.3.3 HLL Life Care Female Emergency Contraceptive Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 HLL Life Care Female Emergency Contraceptive Pill Product Portfolio
- 8.3.5 HLL Life Care Recent Developments
- 8.4 HRA Pharma
- 8.4.1 HRA Pharma Company Information
- 8.4.2 HRA Pharma Business Overview
- 8.4.3 HRA Pharma Female Emergency Contraceptive Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 HRA Pharma Female Emergency Contraceptive Pill Product Portfolio
- 8.4.5 HRA Pharma Recent Developments
- 8.5 Lupin
- 8.5.1 Lupin Company Information
- 8.5.2 Lupin Business Overview
- 8.5.3 Lupin Female Emergency Contraceptive Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Lupin Female Emergency Contraceptive Pill Product Portfolio
- 8.5.5 Lupin Recent Developments
- 8.6 Mankind Pharma
- 8.6.1 Mankind Pharma Company Information
- 8.6.2 Mankind Pharma Business Overview
- 8.6.3 Mankind Pharma Female Emergency Contraceptive Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Mankind Pharma Female Emergency Contraceptive Pill Product Portfolio
- 8.6.5 Mankind Pharma Recent Developments
- 8.7 Piramal
- 8.7.1 Piramal Company Information
- 8.7.2 Piramal Business Overview
- 8.7.3 Piramal Female Emergency Contraceptive Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Piramal Female Emergency Contraceptive Pill Product Portfolio
- 8.7.5 Piramal Recent Developments
- 8.8 Syzygy Healthcare
- 8.8.1 Syzygy Healthcare Company Information
- 8.8.2 Syzygy Healthcare Business Overview
- 8.8.3 Syzygy Healthcare Female Emergency Contraceptive Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Syzygy Healthcare Female Emergency Contraceptive Pill Product Portfolio
- 8.8.5 Syzygy Healthcare Recent Developments
- 8.9 Regenex
- 8.9.1 Regenex Company Information
- 8.9.2 Regenex Business Overview
- 8.9.3 Regenex Female Emergency Contraceptive Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Regenex Female Emergency Contraceptive Pill Product Portfolio
- 8.9.5 Regenex Recent Developments
- 8.10 Zizhu Pharma
- 8.10.1 Zizhu Pharma Company Information
- 8.10.2 Zizhu Pharma Business Overview
- 8.10.3 Zizhu Pharma Female Emergency Contraceptive Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Zizhu Pharma Female Emergency Contraceptive Pill Product Portfolio
- 8.10.5 Zizhu Pharma Recent Developments
- 8.11 Sine Pharma
- 8.11.1 Sine Pharma Company Information
- 8.11.2 Sine Pharma Business Overview
- 8.11.3 Sine Pharma Female Emergency Contraceptive Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Sine Pharma Female Emergency Contraceptive Pill Product Portfolio
- 8.11.5 Sine Pharma Recent Developments
- 8.12 Zhejiang Xianju Pharma
- 8.12.1 Zhejiang Xianju Pharma Company Information
- 8.12.2 Zhejiang Xianju Pharma Business Overview
- 8.12.3 Zhejiang Xianju Pharma Female Emergency Contraceptive Pill Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Zhejiang Xianju Pharma Female Emergency Contraceptive Pill Product Portfolio
- 8.12.5 Zhejiang Xianju Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Female Emergency Contraceptive Pill Value Chain Analysis
- 9.1.1 Female Emergency Contraceptive Pill Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Female Emergency Contraceptive Pill Production Mode & Process
- 9.2 Female Emergency Contraceptive Pill Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Female Emergency Contraceptive Pill Distributors
- 9.2.3 Female Emergency Contraceptive Pill Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst